These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 25247439)

  • 1. Systematic evaluation of "compliance" to prescribed treatment medications and "abstinence" from psychoactive drug abuse in chemical dependence programs: data from the comprehensive analysis of reported drugs.
    Blum K; Han D; Femino J; Smith DE; Saunders S; Simpatico T; Schoenthaler SJ; Oscar-Berman M; Gold MS
    PLoS One; 2014; 9(9):e104275. PubMed ID: 25247439
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Systematic, Intensive Statistical Investigation of Data from the Comprehensive Analysis of Reported Drugs (CARD) for Compliance and Illicit Opioid Abstinence in Substance Addiction Treatment with Buprenorphine/naloxone.
    Blum K; Han D; Modestino EJ; Saunders S; Roy AK; Jacobs W; Inaba DS; Baron D; Oscar-Berman M; Hauser M; Badgaiyan RD; Smith DE; Femino J; Gold MS
    Subst Use Misuse; 2018 Jan; 53(2):220-229. PubMed ID: 29257919
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lower Cutoffs for LC-MS/MS Urine Drug Testing Indicates Better Patient Compliance.
    Krock K; Pesce A; Ritz D; Thomas R; Cua A; Rogers R; Lipnick P; Kilbourn K
    Pain Physician; 2017 Nov; 20(7):E1107-E1113. PubMed ID: 29149155
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New psychoactive substances as part of polydrug abuse within opioid maintenance treatment revealed by comprehensive high-resolution mass spectrometric urine drug screening.
    Heikman P; Sundström M; Pelander A; Ojanperä I
    Hum Psychopharmacol; 2016 Jan; 31(1):44-52. PubMed ID: 26763789
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Optimum methadone compliance testing: an evidence-based analysis.
    Medical Advisory Secretariat
    Ont Health Technol Assess Ser; 2006; 6(21):1-54. PubMed ID: 23074492
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protocol for accuracy of point of care (POC) or in-office urine drug testing (immunoassay) in chronic pain patients: a prospective analysis of immunoassay and liquid chromatography tandem mass spectometry (LC/MS/MS).
    Manchikanti L; Malla Y; Wargo BW; Cash KA; Pampati V; Damron KS; McManus CD; Brandon DE
    Pain Physician; 2010; 13(1):E1-E22. PubMed ID: 20119473
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence of psychotropic drug use in military police units.
    Costa SH; Yonamine M; Ramos AL; Oliveira FG; Rodrigues CR; da Cunha LC
    Cien Saude Colet; 2015 Jun; 20(6):1843-9. PubMed ID: 26060962
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of abuse and dependence on drugs used for self-medication: a pharmacoepidemiological pilot study based on community pharmacies in France.
    Orriols L; Gaillard J; Lapeyre-Mestre M; Roussin A
    Drug Saf; 2009; 32(10):859-73. PubMed ID: 19722729
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Urine drug screen findings among ambulatory oncology patients in a supportive care clinic.
    Rauenzahn S; Sima A; Cassel B; Noreika D; Gomez TH; Ryan L; Wolf CE; Legakis L; Del Fabbro E
    Support Care Cancer; 2017 Jun; 25(6):1859-1864. PubMed ID: 28120116
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Does random urine drug testing reduce illicit drug use in chronic pain patients receiving opioids?
    Manchikanti L; Manchukonda R; Pampati V; Damron KS; Brandon DE; Cash KA; McManus CD
    Pain Physician; 2006 Apr; 9(2):123-9. PubMed ID: 16703972
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Psychoactive substances in biological samples--toxicological laboratory data].
    Gomółka E; Wilimowska J; Piekoszewski W; Groszek B
    Przegl Lek; 2004; 61(4):323-7. PubMed ID: 15521594
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical issues associated with urine testing of substances of abuse.
    Eskridge KD; Guthrie SK
    Pharmacotherapy; 1997; 17(3):497-510. PubMed ID: 9165553
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oral fluid drug testing of chronic pain patients. I. Positive prevalence rates of licit and illicit drugs.
    Heltsley R; DePriest A; Black DL; Robert T; Marshall L; Meadors VM; Caplan YH; Cone EJ
    J Anal Toxicol; 2011 Oct; 35(8):529-40. PubMed ID: 22004671
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ethyl glucuronide: a biomarker to identify alcohol use by health professionals recovering from substance use disorders.
    Skipper GE; Weinmann W; Thierauf A; Schaefer P; Wiesbeck G; Allen JP; Miller M; Wurst FM
    Alcohol Alcohol; 2004; 39(5):445-9. PubMed ID: 15289206
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of lowering the screening and confirmation cutoff values for urine drug testing based on dilution indicators.
    Fraser AD; Zamecnik J
    Ther Drug Monit; 2003 Dec; 25(6):723-7. PubMed ID: 14639059
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Application of drug testing using exhaled breath for compliance monitoring of drug addicts in treatment.
    Carlsson S; Olsson R; Lindkvist I; Beck O
    Scand J Clin Lab Invest; 2015 Apr; 75(2):156-61. PubMed ID: 25562730
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Patterns of drug use by participants in the Western Australian methadone program, 1984-1991.
    Swensen G; Ilett KF; Dusci LJ; Hackett LP; Ong RT; Quigley AJ; Lenton S; Saker R; Caporn J
    Med J Aust; 1993 Sep; 159(6):373-6. PubMed ID: 8104312
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recreational drug use at a major music festival: trend analysis of anonymised pooled urine.
    Hoegberg LCG; Christiansen C; Soe J; Telving R; Andreasen MF; Staerk D; Christrup LL; Kongstad KT
    Clin Toxicol (Phila); 2018 Apr; 56(4):245-255. PubMed ID: 28814125
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Utility of oral fluid in compliance monitoring of opioid medications.
    Conermann T; Gosalia AR; Kabazie AJ; Moore C; Miller K; Fetsch M; Irvan D
    Pain Physician; 2014; 17(1):63-70. PubMed ID: 24452646
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Drug abuse screening with exhaled breath and oral fluid in adults with substance use disorder.
    Arvidsson M; Ullah S; Franck J; Dahl ML; Beck O
    Drug Test Anal; 2019 Jan; 11(1):27-32. PubMed ID: 29575801
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.